BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Influenza
,
Neuron
,
Biofuel
,
Lipitor
,
rs7903146
,
BRAF
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptor epha3
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prost…
The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility.
Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patient…
The Neural Cell Adhesion Molecule (NCAM) Promotes Clustering and Activation of EphA3 Receptors in GA…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Trial of KB004 in Patients With Glioblastoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ